Drugs and the Darknet: Challenges and Opportunities
How the Darknet Is Disrupting the Drug BusinessVoices
Darknet markets, or “cryptomarkets,” are changing the way that people buy, sell, use, and make drugs around the world. These anonymous online markets are democratizing access to global drug supply chains, introducing new challenges and opportunities for supporting the health of people who use the products that flow through them.
This event explored technologies, practices, opportunities, and challenges emerging from cryptomarkets. It presented a framework for understanding the role of cryptomarkets in global drug supply chains and how principles of harm reduction manifest in discourse and practice within them. We examined product innovations seen within cryptomarkets to reduce the health harms related to illicit substances purchased online, explore implications of recent interdiction events, and frame guidelines for the ethical practice of harm reduction service and research in this space.
Daniel Wolfe is director of the International Harm Reduction Development Program at the Open Society Foundations.
Michael Gilbert, MPH, is a public health technologist with a specialization in epidemiology and harm reduction.
Nabarun Dasgupta, MPH, PhD, is an epidemiologist studying the medical and nonmedical use of prescription opioids and heroin at the University of North Carolina at Chapel Hill.
End the Drug War
Reframing the Blame for the War on Drugs
The war on drugs is better understood as a war on people. To stop this useless and unjust destruction, we must change how we think—and talk—about people who use drugs.
Improving Access to Palliative Care During the Global Pain Crisis
A panel of health experts discuss fighting for better access to pain relief for palliative care in India and Latin America.
How the Darknet Is Disrupting the Drug Business
Cryptomarkets are changing the way that people buy, sell, use, and make drugs around the world.